Back to Market Feed

Product Information

RHOPRESSA 0.02% OPHTH SOLUTION is a brand product labeled by Alcon Laboratories, Inc., priced at $131.7573 per ML under NDC 70727049725. Its NADAC has been published 410 times since Oct 17, 2018.

FDA first approved this application on Dec 18, 2017.

RHOPRESSA 0.02% OPHTH SOLUTION

netarsudil
$131.7573per ML

Strength

.2 mg/mL

NDC

70727049725

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC; TOPICAL

Effective Date

8/19/2026

Active Ingredients

NETARSUDIL MESYLATE

Approval Type

New Drug (NDA)

FDA Application

NDA208254

FDA Approved

12/18/2017

On Market Since

12/18/2017

Pharmacological Classes

Rho Kinase Inhibitor
Rho Kinase Inhibitors

Price Statistics

The NADAC for RHOPRESSA 0.02% OPHTH SOLUTION has been published 410 times since Oct 17, 2018, and over the history we have for it it has risen 50.2%. The table below summarizes its recorded NADAC range and movement.

Current price$131.7573 per ML
All-time high$131.9200 (May 13, 2026)
All-time low$87.7131 (Oct 17, 2018)
52-week high$131.9200
52-week low$128.0494
Median price$114.0860
Average price$114.7530
Largest weekly change+9.0% (Nov 28, 2018)
Weeks tracked410
Tracking sinceOct 17, 2018

Price History

1W

+0.1%

1M

+0.1%

3M

-0.0%

6M

-0.1%

1Y

+2.9%

3Y

+10.0%

5Y

+21.2%

All

+50.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the netarsudil market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

ROCKLATAN 0.02%-0.005% EYE DRP
Brand
70727052925•Alcon Laboratories, Inc.
$139.4419
per ML

Frequently asked questions

What is the NADAC price of RHOPRESSA 0.02% OPHTH SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for RHOPRESSA 0.02% OPHTH SOLUTION, manufactured by Alcon Laboratories, Inc., is $131.7573 per ML (NDC 70727049725), effective Aug 19, 2026.

How has the price of RHOPRESSA 0.02% OPHTH SOLUTION changed over time?

Over the history we have for it, the NADAC for RHOPRESSA 0.02% OPHTH SOLUTION has risen 50.2%. It has been tracked across 410 weekly CMS publications since Oct 17, 2018.

What are the highest and lowest recorded NADAC prices for RHOPRESSA 0.02% OPHTH SOLUTION?

Since Oct 17, 2018, the NADAC for RHOPRESSA 0.02% OPHTH SOLUTION has ranged from a low of $87.7131 (Oct 17, 2018) to a high of $131.9200 (May 13, 2026), with a median of $114.0860 per ML.

Are there cheaper alternatives to RHOPRESSA 0.02% OPHTH SOLUTION?

No other NADAC-published product currently shares the active ingredient and strength of RHOPRESSA 0.02% OPHTH SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures RHOPRESSA 0.02% OPHTH SOLUTION?

RHOPRESSA 0.02% OPHTH SOLUTION (NDC 70727049725) is labeled by Alcon Laboratories, Inc., and CMS classifies it as a brand product.